False discovery rate estimation for frequentist pharmacovigilance signal detection methods

Biometrics

Volumn 66, Issue 1, 2010, Pages 301-309

  Ahmed, I ^a,b   Dalmasso, C ^b   Haramburu, F ^c,d   Thiessard, F ^a,d,e   Broet P ^b   Tubert Bitter, P ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c INSERM U657   (France)

^d HÔPITAL PELLEGRIN   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

False discovery rate; Fisher's exact test; Location based estimator; Mid P values; Mixture model; Multiple comparisons; One sided P values; Pharmacovigilance; Reporting odds ratio

Indexed keywords

FALSE DISCOVERY RATE; FISHER EXACT TEST; LOCATION BASED; LOCATION-BASED ESTIMATOR; MID-P-VALUE; MIXTURE MODELING; MULTIPLE COMPARISON; ODD RATIOS; ONE-SIDED P-VALUE; P-VALUES; PHARMACOVIGILANCE; REPORTING ODD RATIO;

SIGNAL GENERATORS;

DATABASE; DECISION MAKING; DRUG; ESTIMATION METHOD; MODEL TEST; SIGNAL PROCESSING; THRESHOLD;

ALGORITHM; AUTOMATED PATTERN RECOGNITION; DECISION SUPPORT SYSTEM; DRUG SURVEILLANCE PROGRAM; HUMAN; LABORATORY DIAGNOSIS; PROCEDURES; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; DATA INTERPRETATION, STATISTICAL; DECISION SUPPORT SYSTEMS, CLINICAL; FALSE POSITIVE REACTIONS; HUMANS; PATTERN RECOGNITION, AUTOMATED;

EID: 77949693566     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2009.01262.x     Document Type: Article

References (27)

1. Agresti, A. (2002). Categorical Data Analysis. Hoboken, New Jersey: Wiley Interscience.
2. Almenoff, J. S., Tonning, J. M., Gould, A. L., Szarfman, A., Hauben, M., Ouellet-Hellstrom, R., Ball, R., Hornbuckle, K., Walsh, L., Yee, C., Sacks, S. T., Yuen, N. A., Patadia, V., Blum, M., Johnston, M., Gerrits, C., Seifert, H., and LaCroix, K. K. (2005). Perspectives on the use of data mining in pharmacovigilance. Drug Safety 28, 981-1007.
3. Bate, A., Lindquist, M., Edwards, I. R., Olsson, S., Orre, R., Lansner, A., and De Freitas, R. M. (1998). A Bayesian neural network method for adverse drug reaction signal generation. European Journal of Clinical Pharmacology 54, 315-321.
4. Benjamini, Y. and Hochberg, Y. (1995). Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society, Series B 57, 289-300.
5. Benjamini, Y., Krieger, A. M., and Yekulti, D. (2006). Adaptive linear step-up procedures that control the false discovery rate. Biometrika 93, 491-507.
6. Brown, E. G., Wood, L., and Wood, S. (1999). The medical dictionary for regulatory activities (MedDRA). Drug Safety 20, 109-117.
7. Dalmasso, C., Bröet, P., and Moreau, T. (2005). A simple procedure for estimating the false discovery rate. Bioinformatics 21, 660-668.
8. DuMouchel, W. (1999). Bayesian data mining in large frequency tables, with an application to the FDA spontaneous reporting system. The American Statistician 53, 177-190.
9. DuMouchel, W. and Pregibon, D. (2001). Empirical Bayes screening for multi-item associations. In KDD'01: Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, 67-76, San Francisco, California.
10. Efron, B. (2007). Correlation and large-scale simultaneous significance testing. Journal of the American Statistical Association 102, 93-103.
11. Evans, S. J., Waller, P. C., and Davis, S. (2001). Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiology and Drug Safety 10, 483-486.
12. Gordon, A., Glazko, G., Qiu, X., and Yakovlev, A. (2007). Control of the mean number of false discoveries, Bonferroni and stability of multiple testing. Annals of Applied Statistics 1, 179-190.
13. Hochberg, Y. and Tamhane, A. C. (1987). Multiple Comparison Procedures. New York: Wiley.
14. Lai, Y. (2007). A moment-based method for estimating the proportion of true null hypotheses and its application to microarray gene expression data. Biostatistics 8, 744-755.
15. Leek, J. T. and Storey, J. (2007). Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3, 1724-1735.
16. Miller, G. C. and Britt, H. (1995). A new drug classification for computer systems: The ATC extension code. International Journal of Bio-Medical Computing 40, 121-124.
17. Noŕen, G. N., Bate, A., Orre, R., and Edwards, I. R. (2006). Extending the methods used to screen the WHO drug safety database towards analysis of complex associations and improved accuracy for rare events. Statistics in Medicine 25, 3740-3757.
18. Pounds, S. and Cheng, C. (2004). Improving false discovery rate estimation. Bioinformatics 20, 1737-1745.
19. Pounds, P. and Cheng, C. (2006). Robust estimation of the false discovery rate. Bioinformatics 22, 1979-1987.
20. Pounds, S. and Morris, S. W. (2003). Estimating the occurrence of false positives and false negatives in microarray studies by approximating and partitioning the empirical distribution of p-values. Bioinformatics 19, 1236-1242.
21. R Development Core Team (2008). R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing. ISBN 3-900051-07-0.
22. Roux, E., Thiessard, F., Fourrier, A., B́egaud, B., and Tubert-Bitter, P. (2005). Evaluation of statistical association measures for the automatic signal generation in pharmacovigilance. IEEE Transactions on Information Technology in Biomedicine 9, 518-527.
23. Storey, J. D. (2002). A direct approach to false discovery rates. Journal of the Royal Statistical Society, Series B 64, 479-498.
24. Storey, J. D. and Tibshirani, R. (2003). Statistical significance for genome-wide studies. Proceedings of the National Academy of Sciences 100, 9440-9445.
25. Thiessard, F., Roux, E., Miremont-Salaḿe, G., Fourrier- Ŕeglat, A., Haramburu, F., Tubert-Bitter, P., and B́egaud, B. (2005). Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986-2001). Drug Safety 28, 731-740.
26. van Puijenbroek, E. P., Bate, A., Leufkens, H. G., Lindquist, M., Orre, R., and Egberts, A. C. (2002). A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions. Pharmacoepidemiology and Drug Safety 11, 3-10.
27. Waller, P., van Puijenbroek, E., Egberts, A., and Evans, S. (2004). The reporting odds ratio versus the proportional reporting ratio: Deuce. Pharmacoepidemiology and Drug Safety 13, 525-526.